YOLFTbeta
06

CTCBIO Inc

060590 · KQ · Healthcare / Biotechnology

2,770.00KRW+105.00 (+3.94%)

Price History

Full chart

Market Stats

Previous Close2,665.00
Open2,695.00
Day Range2,660.00 – 2,835.00
52-Week Range2,570.00 – 5,970.00
Volume114.04K
Market Cap73.76B
P/E (TTM)0.00
Forward P/E62.89
Dividend Yield0.00%
Beta0.02
50-Day Avg3,041.90
200-Day Avg3,671.93

About

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19. In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Sun Cho Chang
  • Employees248
  • HeadquartersTower A, 901, Hwaseong-si, South Korea, Korea
  • Websitehttps://www.ctcbio.com

Leadership

  • Mr. Sun Cho ChangCEO & Executive Director · b. 1963
  • Mr. SinGyu KimCEO & Executive Director · b. 1964
  • Mr. Ho-Yeon ChoPresident · b. 1958
  • Seong-Rin KimPresident · b. 1958
  • Mr. Keumho LeeExecutive Director · b. 1973

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue93.96B129.78B123.39B121.85B118.99B123.15B130.56B138.40B136.12B130.03B140.32B165.21B137.88B144.41B123.77B
Growth (%)-+38.12%-4.93%-1.24%-2.35%+3.49%+6.02%+6.01%-1.64%-4.48%+7.91%+17.74%-16.54%+4.74%-14.29%
Cost of Revenue65.97B87.74B88.57B83.97B83.19B90.77B100.62B101.49B109.49B103.40B106.82B110.35B94.81B91.13B73.45B
Gross Profit---35.57B35.80B32.38B29.94B36.91B26.63B26.63B33.50B54.85B43.07B53.28B50.32B
Gross Margin---29.19%30.09%26.29%22.93%26.67%19.56%20.48%23.87%33.20%31.24%36.90%40.65%
Operating Expense---35.46B33.17B35.01B44.30B44.47B32.05B33.68B38.37B51.56B57.06B56.90B44.07B
Operating Income775.56M11.17B2.10B110.50M2.64B-2.64B-14.36B-7.56B-5.42B-7.05B-4.87B3.29B-13.99B-3.62B6.25B
Operating Margin0.83%8.61%1.70%0.09%2.21%-2.14%-11.00%-5.46%-3.98%-5.42%-3.47%1.99%-10.15%-2.51%5.05%
EBITDA-----------9.80B-6.52B3.44B11.83B
EBITDA Margin-----------5.93%-4.73%2.38%9.56%
Net Income-8.19B864.12M-3.50B2.74B-2.74B-20.70B-9.06B-13.74B-19.46B-7.32B6.75B-15.59B-5.22B3.24B
Net Income Margin-6.31%0.70%-2.87%2.30%-2.22%-15.85%-6.55%-10.09%-14.96%-5.22%4.09%-11.31%-3.62%2.62%
R&D4.73B-4.09B5.95B4.93B7.36B5.78B4.58B-3.91B3.09B2.40B2.64B3.56B1.78B
R&D as % of Total Revenue5.03%-3.31%4.88%4.14%5.98%4.42%3.31%-3.00%2.20%1.45%1.91%2.46%1.44%
Interest Expense0000000004.62B3.65B2.90B3.24B3.20B2.32B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.55%2.60%1.75%2.35%2.22%1.87%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets93.33B125.36B150.48B162.12B193.61B188.68B191.80B191.69B186.50B177.17B168.23B187.90B165.86B153.69B143.24B
Total Liabilities48.52B62.96B58.25B76.63B94.47B97.78B117.82B104.82B111.76B100.86B83.21B91.94B90.42B84.07B70.51B
Total Equity44.80B62.34B92.19B85.44B99.14B90.89B73.98B86.87B74.74B76.32B85.01B95.96B75.44B69.62B72.72B
Cash4.34B11.58B5.21B10.37B2.07B5.00B6.19B4.15B15.23B12.14B41.60M196.00K24.63B19.17B16.75B
Total Debt----67.89B71.26B86.77B75.54B48.87B59.97B-----
Net Debt---------43.46B25.11B9.90B6.46B8.96B18.95B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--2.74B-347.74M1.44B6.86B295.30M-2.47B1.68B510.09M6.46B18.22B8.22B4.50B4.38B
Investing Cash Flow----3.97B-23.36B-5.87B-3.99B-8.22B10.25B1.58B2.15B-3.02B-1.65B-3.22B-
Financing Cash Flow10.60B16.61B20.23B9.52B13.96B1.84B4.88B8.79B-1.28B-4.85B-13.37B1.62B-6.00B-7.26B-
Capital Expenditure8.07B5.49B6.05B27.82B23.71B13.46B3.90B1.50B2.22B1.92B1.67B3.17B1.88B2.14B925.08M
Free Cash Flow----------7.62B3.32B14.26B5.73B2.26B3.46B
FCF to OCF----------1493.67%51.36%78.24%69.70%50.23%78.89%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 16, 2016Nov 11, 2016Feb 17, 2017May 12, 2017Aug 11, 2017Nov 6, 2017Feb 12, 2018May 2, 2018Aug 14, 2018Nov 14, 2018Feb 28, 2019May 15, 2019Aug 13, 2019Nov 14, 2019Feb 26, 2020May 13, 2020Aug 11, 2020Nov 12, 2020Mar 3, 2021Apr 27, 2021Aug 13, 2021Nov 18, 2021May 4, 2022Aug 12, 2022Nov 11, 2022Mar 13, 2023May 3, 2023Aug 14, 2023Nov 16, 2023May 10, 2024Aug 14, 2024Nov 14, 2024Apr 7, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------------
EPS Actual19.0135.5189.0156.9786.208.7955.19-68.34-37.415.387.78-21.03210.5682.89169.81-30.1689.02-47.1444.85-14.99-214.12-46.3273.42105.1526.14-172.14200.0012.82-3.7611.5777.00-101.63-42.49-294.64-752.380.71-128.86-172.25-202.55-71.83-301.69-247.60-100.52-33.36-860.82-82.95-33.5385.54-169.87-275.68286.73106.00-4.00-101.80-71.58-10.95-106.38-11.88-94.31-133.1520.9949.9512.9846.04146.39108.84
Surprise------------------------------------------------------------------
Timing----------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market------------Pre-marketPre-marketPre-market------------

Key Statistics & Ratios

Market Cap73.76B
Enterprise Value89.35B
Trailing P/E0.00
Forward P/E62.89
Price / Sales0.56
Price / Book0.91
Revenue (TTM)131.54B
Gross Profit (TTM)52.76B
EBITDA17.73B
Profit Margin5.71%
Operating Margin11.26%
Return on Equity9.54%
Return on Assets4.79%
Shares Outstanding23.91M
Shares Float13.67M
Beta0.02
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20091×
63.58Dec 29, 2009
20081×
31.79Dec 29, 2008
20071×
31.79Dec 27, 2007
20061×
31.79Dec 27, 2006
20051×
31.79Dec 28, 2005
20041×
29.19Dec 29, 2004

Stock Splits

  • Apr 22, 201398163:89239
  • Mar 5, 20131291:1264
  • Nov 30, 20117:5
  • Oct 28, 2005709:651
  • Dec 29, 20031677:1624
  • Dec 27, 200227:20